يعرض 1 - 10 نتائج من 110 نتيجة بحث عن '"URINARY EXCRETION"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
  2. 2
    مورد إلكتروني

    المصدر: Zamora-Ros , R , Lujan-Barroso , L , Achaintre , D , Franceschi , S , Kyro , C , Overvad , K , Tjonneland , A , Truong , T , Lecuyer , L , Boutron-Ruault , M-C , Katzke , V , Johnson , T S , Schulze , M B , Trichopoulou , A , Peppa , E , La Vechia , C , Masala , G , Pala , V , Panico , S , Tumino , R , Ricceri , F , Skeie , G , Quiros , J R , Rodriguez-Barranco , M , Amiano , P , Chirlaque , M-D , Ardanaz , E , Almquist , M , Hennings , J , Vermeulen , R , Wareham , N J , Tong , T Y N , Aune , D , Byrnes , G , Weiderpass , E , Scalbert , A , Rinaldi , S & Agudo , A 2021 , ' Blood polyphenol concentrations and differentiated thyroid carcinoma in women from the European Prospective Investigation into Cancer and Nutrition (EPIC) study ' , American Journal of Clinical Nutrition , vol. 113 , no. 1 , pp. 162-171 .

  3. 3
    مورد إلكتروني
  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: randomized controlled trial, risk assessment, treatment duration, trough concentration, unspecified side effect/si [Side Effect], urinary excretion, urinary tract infection/dt [Drug Therapy], albumin/ec [Endogenous Compound], alfentanil/cb [Drug Combination], angiotensin receptor antagonist/dt [Drug Therapy], antibiotic agent/dt [Drug Therapy], astemizole/cb [Drug Combination], cisapride/cb [Drug Combination], clarithromycin/cb [Drug Combination], conivaptan/cb [Drug Combination], creatinine/ec [Endogenous Compound], cyclosporine/cb [Drug Combination], dihydroergotamine/cb [Drug Combination], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ergotamine/cb [Drug Combination], fentanyl/cb [Drug Combination], indinavir plus ritonavir/cb [Drug Combination], itraconazole/cb [Drug Combination], ketoconazole/cb [Drug Combination], lopinavir plus ritonavir/cb [Drug Combination], pimozide/cb [Drug Combination], placebo, quinidine/cb [Drug Combination], rapamycin/cb [Drug Combination], reduced nicotinamide adenine dinucleotide phosphate oxidase/ec [Endogenous Compound], ritonavir/cb [Drug Combination], setanaxib/ae [Adverse Drug Reaction], setanaxib/ct [Clinical Trial], setanaxib/cb [Drug Combination], setanaxib/cm [Drug Comparison], setanaxib/cr [Drug Concentration], setanaxib/dt [Drug Therapy], setanaxib/pd [Pharmacology], tacrolimus/cb [Drug Combination], telaprevir/cb [Drug Combination], terfenadine/cb [Drug Combination], voriconazole/cb [Drug Combination], setanaxib/pk [Pharmacokinetics], clinical evaluation, clinical protocol, adult, aged, albuminuria/dt [Drug Therapy], animal experiment, antibiotic therapy, article, controlled study, creatinine blood level, creatinine urine level, diabetic nephropathy/dt [Drug Therapy], diabetic patient, double blind procedure, drug blood level, drug efficacy, drug safety, drug withdrawal, estimated glomerular filtration rate, female, human, insulin dependent diabetes mellitus/dt [Drug Therapy], major clinical study, male, microalbuminuria, mouse, multicenter study, nonhuman, outcome assessment, patient compliance, phase 2 clinical trial, physician, Article

  5. 5
    مورد إلكتروني
  6. 6
    مورد إلكتروني
  7. 7
    مورد إلكتروني
  8. 8
    مورد إلكتروني
  9. 9
    مورد إلكتروني
  10. 10